ID   A0A1V1IGJ9_HUMAN        Unreviewed;       266 AA.
AC   A0A1V1IGJ9;
DT   13-NOV-2019, integrated into UniProtKB/TrEMBL.
DT   13-NOV-2019, sequence version 1.
DT   28-JAN-2026, entry version 30.
DE   SubName: Full=HLA class II histocompatibility antigen DR beta chain {ECO:0000313|EMBL:BBD34093.1};
DE   SubName: Full=MHC class II antigen {ECO:0000313|EMBL:CZQ50734.1};
GN   Name=HLA-DRB1 {ECO:0000313|EMBL:CZQ50734.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:CZQ50734.1};
RN   [1] {ECO:0000313|EMBL:AHW47920.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Pyo C.-W., Wang K., Shen S., Song Y., Wang R., Vu Q., Hall R.J., Eng K.,
RA   Bowman B., Ranade S., Geraghty D.E.;
RT   "Haplotype-resolved resequencing of conserved extended haploytpes
RT   associated with disease using fosmid target capture and long-read SMRT
RT   sequencing technology.";
RL   Submitted (APR-2014) to the EMBL/GenBank/DDBJ databases.
RN   [2] {ECO:0000313|EMBL:CZQ50734.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Oliw E.H.;
RL   Submitted (JAN-2016) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:CZQ50734.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Marsh S.G.E.;
RT   "Full-length genomic HLA sequences.";
RL   Submitted (MAR-2017) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:CZQ50716.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Marsh S.G.E.;
RT   "HLA Class II genomic sequences.";
RL   Submitted (JUL-2017) to the EMBL/GenBank/DDBJ databases.
RN   [5] {ECO:0000313|EMBL:BBD34093.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=30337930; DOI=.3389/fimmu.2018.02294;
RA   Suzuki S., Ranade S., Osaki K., Ito S., Shigenari A., Ohnuki Y., Oka A.,
RA   Masuya A., Harting J., Baybayan P., Kitazume M., Sunaga J., Morishima S.,
RA   Morishima Y., Inoko H., Kulski J.K., Shiina T.;
RT   "Reference Grade Characterization of Polymorphisms in Full-Length HLA Class
RT   I and II Genes With Short-Read Sequencing on the ION PGM System and Long-
RT   Reads Generated by Single Molecule, Real-Time Sequencing on the PacBio
RT   Platform.";
RL   Front. Immunol. 9:2294-2294(2018).
RN   [6] {ECO:0000313|EMBL:CAE6990214.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Turner R T.;
RL   Submitted (JAN-2021) to the EMBL/GenBank/DDBJ databases.
RN   [7] {ECO:0007829|PDB:7O00}
RP   X-RAY CRYSTALLOGRAPHY (2.24 ANGSTROMS) OF 31-219, AND DISULFIDE BONDS.
RX   PubMed=35027402; DOI=10.1136/annrheumdis-2021-220500;
RA   Ge C., Weisse S., Xu B., Dobritzsch D., Viljanen J., Kihlberg J., Do N.N.,
RA   Schneider N., Lanig H., Holmdahl R., Burkhardt H.;
RT   "Key interactions in the trimolecular complex consisting of the rheumatoid
RT   arthritis-associated DRB1*04:01 molecule, the major glycosylated collagen
RT   II peptide and the T-cell receptor.";
RL   Ann. Rheum. Dis. 81:480-489(2022).
RN   [8] {ECO:0007829|PDB:8EUQ}
RP   X-RAY CRYSTALLOGRAPHY (3.09 ANGSTROMS) OF 30-219, GLYCOSYLATION AT ASN-48,
RP   AND DISULFIDE BONDS.
RX   PubMed=37053069; DOI=10.1016/j.celrep.2023.112391;
RA   Kassardjian A., Sun E., Sookhoo J., Muthuraman K., Boligan K.F.,
RA   Kucharska I., Rujas E., Jetha A., Branch D.R., Babiuk S., Barber B.,
RA   Julien J.P.;
RT   "Modular adjuvant-free pan-HLA-DR-immunotargeting subunit vaccine against
RT   SARS-CoV-2 elicits broad sarbecovirus-neutralizing antibody responses.";
RL   Cell Rep. 42:112391-112391(2023).
RN   [9] {ECO:0007829|PDB:7YXB}
RP   X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF 31-227, AND DISULFIDE BONDS.
RX   PubMed=37142807; DOI=10.1038/s41589-023-01316-3;
RA   Abualrous E.T., Stolzenberg S., Sticht J., Wieczorek M., Roske Y.,
RA   Gunther M., Dahn S., Boesen B.B., Calvo M.M., Biese C., Kuppler F.,
RA   Medina-Garcia A., Alvaro-Benito M., Hofer T., Noe F., Freund C.;
RT   "MHC-II dynamics are maintained in HLA-DR allotypes to ensure catalyzed
RT   peptide exchange.";
RL   Nat. Chem. Biol. 19:1196-1204(2023).
RN   [10] {ECO:0007829|PDB:9B7B}
RP   X-RAY CRYSTALLOGRAPHY (3.08 ANGSTROMS) OF 29-219, GLYCOSYLATION AT ASN-48,
RP   AND DISULFIDE BONDS.
RX   PubMed=39051333; DOI=10.3390/antib13030057;
RA   Kassardjian A., Ivanochko D., Barber B., Jetha A., Julien J.P.;
RT   "Humanization of Pan-HLA-DR mAb 44H10 Hinges on Critical Residues in the
RT   Antibody Framework.";
RL   Antibodies 13:57-57(2024).
RN   [11] {ECO:0007829|PDB:9NIH}
RP   X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 30-219, GLYCOSYLATION AT ASN-48,
RP   AND DISULFIDE BONDS.
RA   Dao H.D., Loh T.J., Lim J.J., Rossjohn J.;
RT   "Crystal structure of HLA-DR4 presenting citrullinated Tenascin C
RT   peptide.";
RL   Submitted (FEB-2025) to the PDB data bank.
RN   [12] {ECO:0007829|PDB:9NIG}
RP   X-RAY CRYSTALLOGRAPHY (3.20 ANGSTROMS) OF 31-220, GLYCOSYLATION AT ASN-48,
RP   AND DISULFIDE BONDS.
RA   Dao H.D., Loh T.J., Lim J.J., Rossjohn J.;
RT   "PB TCR in complex with HLA-DR4 presenting citrullinated Tenascin C
RT   peptide.";
RL   Submitted (FEB-2025) to the PDB data bank.
CC   -!- SUBCELLULAR LOCATION: Endosome membrane
CC       {ECO:0000256|ARBA:ARBA00004530}; Single-pass type I membrane protein
CC       {ECO:0000256|ARBA:ARBA00004530}. Lysosome membrane
CC       {ECO:0000256|ARBA:ARBA00004352}; Single-pass type I membrane protein
CC       {ECO:0000256|ARBA:ARBA00004352}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; KJ657694; AHW47920.1; -; Genomic_DNA.
DR   EMBL; KJ657696; AHW47954.1; -; Genomic_DNA.
DR   EMBL; KJ657697; AHW47971.1; -; Genomic_DNA.
DR   EMBL; LC257775; BBD34093.1; -; Genomic_DNA.
DR   EMBL; HG993104; CAE6990214.1; -; Genomic_DNA.
DR   EMBL; LT220230; CZQ50716.1; -; Genomic_DNA.
DR   EMBL; LT220246; CZQ50732.1; -; Genomic_DNA.
DR   EMBL; LT220248; CZQ50734.1; -; Genomic_DNA.
DR   PDB; 7O00; X-ray; 2.24 A; BBB=31-219.
DR   PDB; 7YXB; X-ray; 2.10 A; B/D=31-227.
DR   PDB; 8EUQ; X-ray; 3.09 A; B/G=30-219.
DR   PDB; 9B7B; X-ray; 3.08 A; B/F=29-219.
DR   PDB; 9NIG; X-ray; 3.20 A; B/D/I=31-220.
DR   PDB; 9NIH; X-ray; 2.40 A; B=30-219.
DR   AlphaFoldDB; A0A1V1IGJ9; -.
DR   SMR; A0A1V1IGJ9; -.
DR   IntAct; A0A1V1IGJ9; 5.
DR   PeptideAtlas; A0A1V1IGJ9; -.
DR   GO; GO:0010008; C:endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005765; C:lysosomal membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0042613; C:MHC class II protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0002250; P:adaptive immune response; IEA:UniProtKB-KW.
DR   GO; GO:0002504; P:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II; IEA:UniProtKB-KW.
DR   CDD; cd21000; IgC1_MHC_II_beta_HLA-DR; 1.
DR   FunFam; 2.60.40.10:FF:000116; HLA class II histocompatibility antigen, DRB1-1 beta chain; 1.
DR   FunFam; 3.10.320.10:FF:000001; HLA class II histocompatibility antigen, DRB1-1 beta chain; 1.
DR   Gene3D; 3.10.320.10; Class II Histocompatibility Antigen, M Beta Chain, Chain B, domain 1; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR050160; MHC/Immunoglobulin.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR014745; MHC_II_a/b_N.
DR   InterPro; IPR000353; MHC_II_b_N.
DR   PANTHER; PTHR19944:SF99; HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DRB1 BETA CHAIN; 1.
DR   PANTHER; PTHR19944; MHC CLASS II-RELATED; 1.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00969; MHC_II_beta; 1.
DR   SMART; SM00407; IGc1; 1.
DR   SMART; SM00921; MHC_II_beta; 1.
DR   SUPFAM; SSF48726; Immunoglobulin; 1.
DR   SUPFAM; SSF54452; MHC antigen-recognition domain; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   3D-structure {ECO:0007829|PDB:7O00, ECO:0007829|PDB:7YXB};
KW   Adaptive immunity {ECO:0000256|ARBA:ARBA00023130};
KW   Disulfide bond {ECO:0000256|ARBA:ARBA00023157};
KW   Endosome {ECO:0000256|ARBA:ARBA00022753};
KW   Glycoprotein {ECO:0000256|ARBA:ARBA00023180};
KW   Immunity {ECO:0000256|ARBA:ARBA00022859};
KW   Lysosome {ECO:0000256|ARBA:ARBA00023228};
KW   Membrane {ECO:0000256|ARBA:ARBA00023136, ECO:0000256|SAM:Phobius};
KW   MHC II {ECO:0000256|ARBA:ARBA00023182};
KW   Signal {ECO:0000256|ARBA:ARBA00022729, ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|ARBA:ARBA00022692, ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|ARBA:ARBA00022989,
KW   ECO:0000256|SAM:Phobius}.
FT   SIGNAL          1..29
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           30..266
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5044063093"
FT   TRANSMEM        228..250
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          126..214
FT                   /note="Ig-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50835"
FT   CARBOHYD        48
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0007829|PDB:7O00, ECO:0007829|PDB:8EUQ"
FT   DISULFID        44..108
FT                   /evidence="ECO:0007829|PDB:7O00, ECO:0007829|PDB:7YXB"
FT   DISULFID        146..202
FT                   /evidence="ECO:0007829|PDB:7O00, ECO:0007829|PDB:7YXB"
SQ   SEQUENCE   266 AA;  30112 MW;  8116E91DA38294E5 CRC64;
     MVCLKFPGGS CMAALTVTLM VLSSPLALAG DTRPRFLEQV KHECHFFNGT ERVRFLDRYF
     YHQEEYVRFD SDVGEYRAVT ELGRPDAEYW NSQKDLLEQK RAAVDTYCRH NYGVGESFTV
     QRRVYPEVTV YPAKTQPLQH HNLLVCSVNG FYPGSIEVRW FRNGQEEKTG VVSTGLIQNG
     DWTFQTLVML ETVPRSGEVY TCQVEHPSLT SPLTVEWRAR SESAQSKMLS GVGGFVLGLL
     FLGAGLFIYF RNQKGHSGLQ PTGFLS
//
